Trump Orders FDA to Fast-Track Psychedelic Treatments
President Trump signed an executive order directing the FDA to expedite psychedelic drug access through breakthrough designation and right-to-try pathways. FDA Commissioner Marty Makary said three priority review vouchers for serotonin 2a agonists will be issued next week, with broader agency decisions expected this